Skip to main content

Advertisement

SpringerLink
Log in

Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Campo E, Jaffe ES, Cook JR, Quintanilla-Martinez L, Swerdlow SH, Anderson KC, Brousset P, Cerroni L, de Leval L, Dirnhofer S, Dogan A, Feldman AL, Fend F, Friedberg JW, Gaulard P, Ghia P, Horwitz SM, King RL, Salles G, San-Miguel J, Seymour JF, Treon SP, Vose JM, Zucca E, Advani R, Ansell S, Au W-Y, Barrionuevo C, Bergsagel L, Chan WC, Cohen JI, d’Amore F, Davies A, Falini B, Ghobrial IM, Goodlad JR, Gribben JG, Hsi ED, Kahl BS, Kim W-S, Kumar S, LaCasce AS, Laurent C, Lenz G, Leonard JP, Link MP, Lopez-Guillermo A, Mateos MV, Macintyre E, Melnick AM, Morschhauser F, Nakamura S, Narbaitz M, Pavlovsky A, Pileri SA, Piris M, Pro B, Rajkumar V, Rosen ST, Sander B, Sehn L, Shipp MA, Smith SM, Staudt LM, Thieblemont C, Tousseyn T, Wilson WH, Yoshino T, Zinzani P-L, Dreyling M, Scott DW, Winter JN, Zelenetz AD (2022) The international consensus classification of mature lymphoid neoplasms: a report from the Clinical Advisory Committee. Blood 140(11):1229–1253

    Article  CAS  PubMed  Google Scholar 

  2. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (2016) The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 127(20):2375–90. https://doi.org/10.1182/blood-2016-01-643569

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Peyrade F, Jardin F, Thieblemont C, Thyss A, Emile JF, Castaigne S, Coiffier B, Haioun C, Bologna S, Fitoussi O, Lepeu G, Fruchart C, Bordessoule D, Blanc M, Delarue R, Janvier M, Salles B, André M, Fournier M, Gaulard P, Tilly H, Grouped’Etude des Lymphomes de l’Adulte (GELA) investigators (2011) Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial. Lancet Oncol 12(5):460–8. https://doi.org/10.1016/S1470-2045(11)70069-9

    Article  CAS  PubMed  Google Scholar 

  4. Dunleavy K, Pittaluga S, Shovlin M, Steinberg SM, Cole D, Grant C, Widemann B, Staudt LM, Jaffe ES, Little RF, Wilson WH (2013) Low-intensity therapy in adults with Burkitt’s lymphoma. N Engl J Med 369(20):1915–1925. https://doi.org/10.1056/NEJMoa1308392

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Kuhlman JJ, Moustafa MA, Jiang L, Iqbal M, Seegobin K, Wolcott Z, Ayala E, Ansell S, Rosenthal A, Paludo J, Micallef I, Johnston P, Inwards D, Habermann T, Kharfan-Dabaja M, Witzig TE, Nowakowski GS, Tun HW (2022) Leukemic high grade B cell lymphoma is associated with MYC translocation, double hit/triple hit status, transformation, and CNS disease risk: the Mayo Clinic experience. Clin Lymphoma Myeloma Leuk 22(8):e815–e825. https://doi.org/10.1016/j.clml.2022.04.009

    Article  CAS  PubMed  Google Scholar 

  6. Zou D, Yi S, Cui R, Liu W, Li C, Zhong S, Yu Z, Li Z, Lv R, Ru K, Wang H, An G, Xu Y, Qiu L (2017) BCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase. BMC Med Genet 18(1):16. https://doi.org/10.1186/s12881-017-0381-z

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Muringampurath-John D, Jaye DL, Flowers CR, Saxe D, Chen Z, Lechowicz MJ, Weisenburger DD, Bast M, Arellano ML, Bernal-Mizrachi L, Heffner LT, McLemore M, Kaufman JL, Winton EF, Lonial S, Armitage JO, Khoury HJ (2012) Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase. Br J Haematol 158(5):608–614. https://doi.org/10.1111/j.1365-2141.2012.09209.x

    Article  PubMed  Google Scholar 

  8. Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH (2013) Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med 368(15):1408–1416. https://doi.org/10.1056/NEJMoa1214561

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Roschewski M, Dunleavy K, Abramson JS, Powell BL, Link BK, Patel P, Bierman PJ, Jagadeesh D, Mitsuyasu RT, Peace D, Watson PR, Hanna WT, Melani C, Lucas AN, Steinberg SM, Pittaluga S, Jaffe ES, Friedberg JW, Kahl BS, Little RF, Bartlett NL, Fanale MA, Noy A, Wilson WH (2020) Multicenter study of risk-adapted therapy with dose-adjusted EPOCH-R in adults with untreated Burkitt lymphoma. J Clin Oncol 38(22):2519–2529. https://doi.org/10.1200/JCO.20.00303

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP (2019) Dose-adjusted EPOCH-R compared with R-CHOP as frontline therapy for diffuse large B-cell lymphoma: clinical outcomes of the phase III intergroup trial alliance/CALGB 50303. J Clin Oncol 37(21):1790–1799. https://doi.org/10.1200/JCO.18.01994

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Vassilakopoulos TP, Papageorgiou S, Angelopoulou M, Petevi K, Anastasopoulou A, Stavroulaki A, Konstantinidou P, Kotsianidis J, Kyrtsonis MC, Siakantaris MP, Kokoris S, Kalpadakis C, Dimou M, Georgiou G, Moschogiannis M, Yiakoumis X, Pappis V, Tsopra O, Tsatalas K, Papadaki H, Dervenoulas J, Panayiotidis P, Meletis J, Pangalis G, Constantinou N (2011) Diffuse large B-cell lymphoma (DLBCL) in very elderly patients (older than 80 years): Promising results in the era of chemoimmunotherapy despite lower dose intensity 16th Congress of the European Haematology Association, June 9–12, 2011, London, UK. Haematologica Hematol J 96(Suppl 2):438 (Oral Presentation)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Haematology and Bone Marrow Transplantation, School of Medicine, Laikon General Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Marina Belia, Ioannis Drandakis, Maria Arapaki, Fotios Panitsas, Evangelia-Fedra Triantafyllou, Eleni Plata, Marina P. Siakantaris, Maria K. Angelopoulou & Theodoros P. Vassilakopoulos

  2. Department of Pathology, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece

    Eleftheria Lakiotaki & Penelope Korkolopoulou

Authors
  1. Marina Belia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ioannis Drandakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Eleftheria Lakiotaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Arapaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fotios Panitsas
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Evangelia-Fedra Triantafyllou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Eleni Plata
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marina P. Siakantaris
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Maria K. Angelopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Penelope Korkolopoulou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Theodoros P. Vassilakopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodoros P. Vassilakopoulos.

Ethics declarations

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from the participant included in the study.

Conflict of interest

Theodoros P. Vassilakopoulos has participated in advisory board committees and received honoraria and research grants from Roche. Maria K. Angelopoulou has participated in advisory board committees and received honoraria from Roche. All other authors declare that they have no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Belia, M., Drandakis, I., Lakiotaki, E. et al. Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version. Ann Hematol 102, 2279–2282 (2023). https://doi.org/10.1007/s00277-023-05214-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05214-5

Search

Navigation